DS
Therapeutic Areas
Strides Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Generic Portfolio | Various | Approved |
| Softgel Portfolio | Pain, Nutrition, Dermatology | Approved |
| Trastuzumab Biosimilar | HER2+ Breast & Gastric Cancer | Phase 3 |
| Pegfilgrastim Biosimilar | Chemotherapy-induced Neutropenia | Phase 3 |
| Bevacizumab Biosimilar | Colorectal, Lung Cancer | Development |
| Complex Generic Injectables | Oncology, Critical Care | Filed/Development |
| Controlled Substance Products | Pain Management, ADHD | Filed/Approved |
| Antiretroviral (ARV) Portfolio | HIV/AIDS | Approved |
Leadership Team at Strides Pharma
AK
Arun Kumar
Founder & Executive Chairperson
RA
R. Ananthanarayanan (Anthy)
Chief Executive Officer & Managing Director
VS
V. S. Mani
Global Chief Financial Officer
SP
Sharvil Patel
Managing Director, India Business & Head - Corporate Strategy
DR
Dr. R. K. Dey
President - Global R&D
MP
M. Prabhakar
Chief Operating Officer - Regulated Markets
SA
Saurabh Agarwal
Chief Operating Officer - Emerging Markets
VK
Vijay Kumar Murthy
Company Secretary & Compliance Officer
DA
Dr. Ashok S. Ganguly
Independent Director
MS
Ms. Shobana Kamineni
Independent Director